Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach

Eur J Rheumatol. 2019 Jan;6(1):60-61. doi: 10.5152/eurjrheum.2018.17188.
No abstract available

Publication types

  • Letter